Merck & Company, Inc. News Headlines

MRK 
$58.44
*  
0.14
0.24%
Get MRK Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dow Movers: V, MSFT
3/28/2014 12:48:48 PM - BNK Invest

Aegerion Pharmaceuticals Viability Threatened As Regulatory, Legal And Market Forces Close In
3/28/2014 11:00:00 AM - Seeking Alpha

What If Merck Challenges Gilead Sciences In Hepatitis C Market?
3/27/2014 4:52:00 PM - Seeking Alpha

Dow Movers: DIS, PG
3/27/2014 1:58:21 PM - BNK Invest

Dow Analyst Moves: MRK
3/27/2014 1:46:10 PM - BNK Invest

Merck Snags Baxter Executive As CFO
3/27/2014 10:42:00 AM - Fox Business

The Richest Man In History Reveals His Simple Wealth Generating Secret
3/27/2014 8:56:00 AM - Seeking Alpha

10 Healthcare Dogs Prescribe 6% To 16% March Upsides
3/26/2014 5:59:00 PM - Seeking Alpha

Small-Caps Lead the Laggards as Intraday Volatility Continues
3/26/2014 4:21:02 PM - Schaeffer's Investment Research

Recent Trials Could Help Pfizer Solidify Its Dominance In Pneumococcal Vaccine Market
3/26/2014 1:51:27 PM - Trefis

Dow Movers: PG, MRK
3/26/2014 1:38:13 PM - BNK Invest

Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
3/26/2014 1:17:00 AM - Investopedia

OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals
3/25/2014 1:35:00 PM - Seeking Alpha

Dow Movers: WMT, CAT
3/25/2014 1:22:31 PM - BNK Invest

Tetraphase's Eravacycline Holds Promise - Analyst Blog
3/25/2014 11:30:01 AM - Zacks.com

Johnson & Johnson's Sale Of K-Y Brand To Reckitt Benckiser Confirms Focus on Pharma
3/24/2014 1:55:19 PM - Trefis

One Put, One Call Option To Know About for Merck & Co.
3/24/2014 11:58:16 AM - BNK Invest

Closing Update: Markets Drift Lower in Afternoon Swoon; Bullard Comments Reinforce Bearish Mood
3/21/2014 4:09:49 PM - MT Newswires

Healthcare Stocks Mixed at Mid-Day; Endocyte Nearly Doubles In Price On Chemotherapy Test Results
3/21/2014 1:11:39 PM - MT Newswires

Sector Update: Healthcare
3/21/2014 1:08:49 PM - MT Newswires

Midday Update: Wall Street Resumes Bull Trend, Shrugs off Yellen and Geo-Political Concerns
3/21/2014 12:15:24 PM - MT Newswires

Notable ETF Inflow Detected - OEF, BRK.B, MRK, KO
3/21/2014 10:58:18 AM - BNK Invest

Dow Movers: MSFT, UNH
3/19/2014 11:52:50 AM - BNK Invest

Milestone Payment for Ligand Pharma - Analyst Blog
3/18/2014 5:30:01 PM - Zacks.com

Maverick Capital buys a position in Valeant Pharmaceuticals
3/17/2014 1:00:00 PM - Market Realist